{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Cognitive frailty", "Gut microbiota", "Inflammation", "Oxidative stress", "Oxygen-ozone therapy", "Trace elements"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "31982474", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "08"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "04"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "01", "Day": "23"}], "ELocationID": ["10.1016/j.mad.2020.111210", "S0047-6374(20)30004-X"], "Journal": {"ISSN": "1872-6216", "JournalIssue": {"Volume": "186", "PubDate": {"Year": "2020", "Month": "Mar"}}, "Title": "Mechanisms of ageing and development", "ISOAbbreviation": "Mech Ageing Dev"}, "ArticleTitle": "Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment.", "Pagination": {"StartPage": "111210", "MedlinePgn": "111210"}, "Abstract": {"AbstractText": ["In the last decade, cognitive frailty has gained great attention from the scientific community. It is characterized by high inflammation and oxidant state, endocrine and metabolic alterations, mitochondria dysfunctions and slowdown in regenerative processes and immune system, with a complex and multifactorial aetiology. Although several treatments are available, challenges regarding the efficacy and the costs persist. Here, we proposed an alternative non-pharmacological, non-side-effect, low cost therapy based on anti-inflammation, antioxidant, regenerative and anti-pathogens properties of ozone, through the activation of several molecular mechanisms (Nrf2-ARE, NF-\u03baB, NFAT, AP-1, HIF\u03b1). We highlighted how these specific processes could be implicated in cognitive frailty to identify putative therapeutic targets for its treatment. The oxigen-ozone (O<sub>2</sub>-O<sub>3</sub>) therapy has never been tested for cognitive frailty. This work provides thus wide scientific background to build a consistent rationale for testing for the first time this therapy, that could modulate the immune, inflammatory, oxidant, metabolic, endocrine, microbiota and regenerative processes impaired in cognitive frailty. Although insights are needed, the O<sub>2</sub>-O<sub>3</sub> therapy could represent a faster, easier, inexpensive monodomain intervention working in absence of side effects for cognitive frailty."], "CopyrightInformation": "Copyright \u00a9 2020 The Authors. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}], "LastName": "Scassellati", "ForeName": "Catia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}], "LastName": "Ciani", "ForeName": "Miriam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Oxygen-Ozone Therapy Scientific Society (SIOOT), Gorle, Italy; University of Pavia, Pavia, Italy."}], "LastName": "Galoforo", "ForeName": "Antonio Carlo", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}], "LastName": "Zanardini", "ForeName": "Roberta", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. Electronic address: cbonvicini@fatebenefratelli.eu."}], "LastName": "Bonvicini", "ForeName": "Cristian", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Alzheimer Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}], "LastName": "Geroldi", "ForeName": "Cristina", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "Mech Ageing Dev", "NlmUniqueID": "0347227", "ISSNLinking": "0047-6374"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "CommentsCorrectionsList": [{"RefSource": "Mech Ageing Dev. 2022 Oct;207:111729. doi: 10.1016/j.mad.2022.111729", "PMID": "36058726"}], "MeshHeadingList": [{"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Cellular Senescence"}, {"QualifierName": ["physiology"], "DescriptorName": "Cognitive Aging"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}], "CoiStatement": "Declaration of Competing Interest The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "9", "Day": "18"}, {"Year": "2020", "Month": "1", "Day": "14"}, {"Year": "2020", "Month": "1", "Day": "21"}, {"Year": "2020", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31982474", "10.1016/j.mad.2020.111210", "S0047-6374(20)30004-X"]}}], "PubmedBookArticle": []}